1. Home
  2. SER vs MGLD Comparison

SER vs MGLD Comparison

Compare SER & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • MGLD
  • Stock Information
  • Founded
  • SER 2017
  • MGLD 1996
  • Country
  • SER United States
  • MGLD United States
  • Employees
  • SER N/A
  • MGLD N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • MGLD Finance/Investors Services
  • Sector
  • SER Health Care
  • MGLD Finance
  • Exchange
  • SER Nasdaq
  • MGLD Nasdaq
  • Market Cap
  • SER 56.5M
  • MGLD 35.8M
  • IPO Year
  • SER 2018
  • MGLD N/A
  • Fundamental
  • Price
  • SER $5.35
  • MGLD $0.82
  • Analyst Decision
  • SER Strong Buy
  • MGLD
  • Analyst Count
  • SER 2
  • MGLD 0
  • Target Price
  • SER $13.00
  • MGLD N/A
  • AVG Volume (30 Days)
  • SER 21.5K
  • MGLD 17.6K
  • Earning Date
  • SER 08-08-2025
  • MGLD 05-08-2025
  • Dividend Yield
  • SER N/A
  • MGLD N/A
  • EPS Growth
  • SER N/A
  • MGLD N/A
  • EPS
  • SER N/A
  • MGLD N/A
  • Revenue
  • SER $51,000.00
  • MGLD $31,205,000.00
  • Revenue This Year
  • SER N/A
  • MGLD N/A
  • Revenue Next Year
  • SER N/A
  • MGLD N/A
  • P/E Ratio
  • SER N/A
  • MGLD N/A
  • Revenue Growth
  • SER N/A
  • MGLD N/A
  • 52 Week Low
  • SER $3.81
  • MGLD $0.70
  • 52 Week High
  • SER $11.57
  • MGLD $2.10
  • Technical
  • Relative Strength Index (RSI)
  • SER 46.11
  • MGLD 43.12
  • Support Level
  • SER $4.93
  • MGLD $0.77
  • Resistance Level
  • SER $6.15
  • MGLD $0.82
  • Average True Range (ATR)
  • SER 0.46
  • MGLD 0.06
  • MACD
  • SER -0.06
  • MGLD -0.00
  • Stochastic Oscillator
  • SER 41.62
  • MGLD 5.08

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About MGLD The Marygold Companies Inc.

The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.

Share on Social Networks: